Psychiatric Drug Development: Diagnosing a Crisis

Although one in five Americans currently takes at least one psychiatric drug and mental disorders are recognized worldwide, global pharmaceutical industry funding for new, innovative medications is in serious decline despite promising advances in genetics. The author traces the evolution of psychiat...

Descripción completa

Detalles Bibliográficos
Autor principal: Hyman, Steven E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Dana Foundation 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662213/
https://www.ncbi.nlm.nih.gov/pubmed/23720708
_version_ 1782270822433423360
author Hyman, Steven E.
author_facet Hyman, Steven E.
author_sort Hyman, Steven E.
collection PubMed
description Although one in five Americans currently takes at least one psychiatric drug and mental disorders are recognized worldwide, global pharmaceutical industry funding for new, innovative medications is in serious decline despite promising advances in genetics. The author traces the evolution of psychiatric drug development, the reasons for its retreat, and the changes necessary to meet the growing demand.
format Online
Article
Text
id pubmed-3662213
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher The Dana Foundation
record_format MEDLINE/PubMed
spelling pubmed-36622132013-05-29 Psychiatric Drug Development: Diagnosing a Crisis Hyman, Steven E. Cerebrum Articles Although one in five Americans currently takes at least one psychiatric drug and mental disorders are recognized worldwide, global pharmaceutical industry funding for new, innovative medications is in serious decline despite promising advances in genetics. The author traces the evolution of psychiatric drug development, the reasons for its retreat, and the changes necessary to meet the growing demand. The Dana Foundation 2013-04-02 /pmc/articles/PMC3662213/ /pubmed/23720708 Text en Copyright 2013 The Dana Foundation All Rights Reserved
spellingShingle Articles
Hyman, Steven E.
Psychiatric Drug Development: Diagnosing a Crisis
title Psychiatric Drug Development: Diagnosing a Crisis
title_full Psychiatric Drug Development: Diagnosing a Crisis
title_fullStr Psychiatric Drug Development: Diagnosing a Crisis
title_full_unstemmed Psychiatric Drug Development: Diagnosing a Crisis
title_short Psychiatric Drug Development: Diagnosing a Crisis
title_sort psychiatric drug development: diagnosing a crisis
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662213/
https://www.ncbi.nlm.nih.gov/pubmed/23720708
work_keys_str_mv AT hymanstevene psychiatricdrugdevelopmentdiagnosingacrisis

Ejemplares similares